Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...

The innate immune system is the body's first line of defense against pathogens and foreign substances. An essential component ...

Ribosomes are tiny molecular machines inside all living cells that build proteins, and ribosome biogenesis is the complex, ...

Researchers develop a self-regulating mRNA medicine that adjusts protein production based on disease-related signals. A research team from The University of Osaka and Institute of Science Tokyo ...

A more effective vaccine technology may be on the horizon. In a new study in mice, researchers from the University of Copenhagen demonstrate that a simple addition to mRNA vaccines can significantly ...

“The CRDMO space for mRNA became crowded during the pandemic, but much of that production process was built for capacity and not flexibility. We’re now seeing a clear shift toward personalized ...

Two other components making moves today are Lockheed Martin, trading down 1.6%, and Incyte, trading up 4.3% on the day. VIDEO: S&P 500 Movers: MRNA, PLTR The views and opinions expressed herein ...

It will combine Ethris’ advanced technology platforms with Thermo Fisher’s good manufacturing practice-compliant manufacturing capabilities. Ethris CEO Carsten Rudolph stated: “Thermo Fisher ...

The US Food and Drug Administration (FDA) has expanded approval of Moderna’s respiratory syncytial virus (RSV) vaccine to include younger adults at risk, though its still uncertain whether the shot ...

A GROUNDBREAKING approach using mRNA-lipid nanoparticle technology has shown the ability to force HIV out of its latent state, offering hope for future curative therapies. Latent HIV, harboured in ...